1. Several agonists modulate cholinergic neurotransmission in airways raising the possibility that there may, be a common inhibitory mechanism, such as the activation of a common K' channel in the nerve ending. To test this hypothesis, we examined whether blockers of K' channels are able to depress the prejunctional inhibitory modulation of cholinergic contractile responses by various agonists in guinea-pig and human airways in vitro.
INTRODUCTION
Cholinergic nerves are the dominant neural bronchoconstrictor mechanism in all species (Barnes, 1986) . Airway cholinergic neural responses are modulated prejunctionally by various receptors , such as x2-adrenoceptors (Grundstrom, Andersson & Wickberg, 1981) , /?2-adrenoceptors (Rhoden, Meldrum & Barnes, 1988) , neuropeptide Y (NPY) receptors (Stretton & Barnes, 1988; Matran, Martling & Lundberg, 1989 ), It-opioid receptors (Belvisi, Stretton & Barnes, 1990) , histamine H3 receptors (Ichinose, Stretton, Schwartz & Barnes, 1989) and vasoactive intestinal peptide (VIP) receptors (Ellis & Farmer, 1989) . The presynaptic inhibitory modulation of neurotransmitter release is thought to involve receptor-mediated regulation of ion channels in the nerve endings (Miller, 1990) . In the central nervous system (CNS), some agonists inhibit neuronal function by opening a common potassium (K+) channel (North, Williams, Surprenant & Christie, 1987) . The presence of several types of K+ channels on nerve cells has been reported, including voltage-sensitive K+ channels (K+) (Mackinnon & Yellen, 1990) , large conductance calcium (Ca2+)-activated K+ channels (K'a) (Reinhart, Chung & Levitan, 1989) , small conductance K~a (Blatz & Magleby, 1986 ) and ATP-sensitive K+ channels (KATP) (Schmid-Antomarchi, Amoroso, Fosset & Lazdunski, 1990) . We have previously reported that charybdotoxin (ChTX), a large conductance K~a blocker (Miller, Moczydlowski, Latorre & Phillips, 1985) , prevented the inhibitory modulation of airway sensory nerves by several agonists in guinea-pigs (Stretton, Miura, Belvisi & Barnes, 1992) , suggesting that the activation of ChTX-sensitive K+ channels may be involved in this inhibitory modulation of peripheral nerves. The present study was undertaken to examine functionally whether K+ channels are involved in the inhibitory modulation of cholinergic nerves in guinea-pig and human airways. NPY, an a2-agonist, a /a-opioid agonist and a KATP opener in guinea-pig trachea and a ,u-opioid in human tissues were used as prejunctional modulators, because the inhibitory modulation of each drug has been established in each species (Grundstrom et al. 1981; Stretton & Barnes, 1988; Belvisi et al. 1990; Belvisi, Stretton, Verleden, Ledingham, Yacoub & Barnes, 1992) and some of these agonists are shown to increase K+ conductance in the CNS (North et al. 1987) . Three types of K+ channel blocker, ChTX, apamin, a small conductance K+a blocker (Banks, Brown, Burgess, Burnstock, Claret, Cocks & Jenkinson, 1979) , and glibenclamide, a KATP blocker (Cook & Hales, 1984) , were also used in order to elucidate the type of K+ channel involved.
METHODS

Tis8sue preparation
Male Dunkin-Hartley guinea-pigs were killed by cervical dislocation and the trachea and lungs were rapidly removed. After being stripped of connective tissue, the trachea was opened up longitudinally by cutting through the cartilage. The upper trachea was cut into segments so that each segment contained three to four cartilage rings.
Human tissues were obtained from five heart donor patients with brain death (mean age 24 years, range 16-35 years, all male). Human lung tissues were immediately placed in oxygenated Krebs-Henseleit (K-H) solution cooled to 4°C and transported to the laboratory. The experiments were performed 6-12 h after the removal of the lungs. The composition of K-H solution was as 2 K+ CHANNELS AND (CzHOLINERGIC AIR WAY RESPOINSES follows (mm): NaCl, 118; KCl. 59; MgSO4, 12; CaCl2, [2] [3] [4] [5] NaH2PO4, 12; NaHCO3, and glucose, [5] [6] . After being stripped of adjacent connective tissues and cartilage, the membranous portion of the trachea or main bronchi was cut horizontally into strips 2 mm wide.
All the tissues were suspended in a 10 ml organ bath containing K-H solution at 37 TC with 95 %°2 and 5% CO2 (pH 7 4). Indomethacin (10' M) was present throughout the experiment, in order to avoid modulation of neurotransmission by endogenously generated prostaglandins. Strips were connected via silk threads to Grass FT.03 force displacement transducers (Grass Instruments, Quincy, MA, USA) for the measurement of isometric changes in tension, and the responses were recorded on a polygraph (Grass Model 7D). The tissues were allowed to equilibrate for 1 h with frequent washing under a resting tension of 1 g for the guinea-pig tissue or 2 g for the human tissue, which were found to be optimal for measuring changes in tension.
Electrical field stimulation
Electrical field stimulation (EFS) was delivered by two platinum wire field electrodes inserted into the organ baths and connected to a Grass S88 stimulator. Biphasic square wave pulses with a supramaximal voltage of 40 V at source, 0 5 ms duration and 0 5 Hz for the guinea-pig tissue or 1 Hz for the human tissue were applied for 15 s every 4 min. These frequencies were chosen because in previous studies they gave the greatest prejunctional inhibitory effects (Stretton & Barnes, 1988; Belvisi et al. 1990 Belvisi et al. , 1992 . Contractile responses obtained to EFS were completely blocked by atropine (2 x 10-6 m) and tetrodotoxin (2 x lo-6 M) individually, indicating that the contractile response was due to stimulation of cholinergic nerves.
Reversal effects of K+ channel blockers on the inhibitory modulation of cholinergic nerves
After constant responses to EFS were obtained in guinea-pig tissues, NPY (10-7 M), an a2adrenoceptor agonist, clonidine (10-8 M), a /u-opioid agonist, [D-Ala2, NMePhe4, Gly-o15]-enkephalin (DAMGO, 10 M), or a KATP opener, lemakalim (BRL38227, 3 x 10-7 M) (Black, Armor, Johnson, Alouan & were added to the baths in order to produce prejunctional inhibition of cholinergic responses. The concentration of each agonist was determined from previous studies (Stretton & Barnes, 1988; Matran et al. 1989; Belvisi et al. 1990) or from preliminary studies to cause approximately 50% inhibition of cholinergic neural responses. After this inhibition had reached a plateau for each agonist, ChTX (10-8 M) was added to half the tissues in order to examine its reversal effects. In other experiments, the reversal effects of apamin (10-7 M) or glibenclamide (10-5 M) were examined following the same protocol.
Effect of charybdotoxin pretreatment on the prejunctional inhibition of cholinergic responses In this series of experiments using guinea-pigs, the effect of ChTX alone on cholinergic contraction was firstly examined. After a constant response to EFS had been obtained, half the tissues were incubated with ChTX (10-8 M). After any change in cholinergic responses caused by ChTX addition had reached a plateau, NPY (10-7 M), clonidine (10 8M), DAMGO (10-7 M) or lemakalim (3 x 10-7 M) were added.
Contractile response study
The effect of ChTX (1 -8 M) on the responses induced by exogenously applied acetylcholine (ACh, 10 M-10-3 M) was also examined in guinea-pig trachea in order to determine whether effects obtained bv ChTX on cholinergic responses were prejunctional.
Effect of charybdotoxin in human airways
After constant responses to EFS were obtained. DAMGO (3 x 10-7 M) was added to all of the tissues. ChTX (10-8 M) was also added at the same time in half the tissues. In another set of experiments, the effect of ChTX (10 8 m) alone was also examined. In every experiment, we confirmed the stability of cholinergic responses during the course of the experiment in untreated tissues. 
Drugs
Drugs and chemicals were obtained from the following sources: indomethacin. neuropeptide Y.
[D-Ala2. NMePhe4. Gly-ol5]-enkephalin, atropine sulphate. apamin. glibenclamide. tetrodotoxin (Sigma Chemicals, Poole, UK). charybdotoxin (Receptor Research Chemicals Inc., Baltimore, AlI), USA), clonidine (Boehringer Ingelheim, Bracknell, UK), lemakalim (BRT,38227) kindly supplied by SmithKline Beecham Pharmaceuticals (Surrey, UK). Indomethacin was made up in alkaline phosphate buffer (pH 7-8) of the following composition (mm): KH2PO4, 20; Na2HPO4. 120. Glibenclamide and lemakalim (both 10 mni) were dissolved in 100% dimethyl sulphoxide. All concentrations refer to the final bath concentration. K+ CHANNV.,VELS AND CHOLINERGIC AIR WA Y RESPONSES
Data analysis
Contractile responses were expressed as absolute changes in tension, and then transformed to a mean response for four control stimulations obtained to EFS in each tissue. Effects of exogenously applied drugs on cholinergic contractile responses were expressed as a percentage of its initial mean response. The effects of K+ channel blockers on the inhibitory modulation were also evaluated by percentage recovery, defined as the ratio of the recovery by K+ channel blockers to the inhibition measured at the plateau phase by prejunctional modulators in absolute values of cholinergic responses.
When the effect of ChTX pretreatment on the inhibitory modulation was assessed, a mean response for four stimulations obtained after ChTX-induced changes had reached a plateau was considered as its initial value.
Comparison of data between different tissues was assessed by unpaired Student's t test, and paired t test was used for evaluation of drug effects in the same tissue. P values < 005 were considered significant. in lemakalim-induced inhibition by ChTX was significantly less than with the other three agonist-induced inhibitory effects (P < 0 05). In the same protocol, apamin (10' M) was without effect on prejunctional modulation of cholinergic responses by any agonist (Fig. 3A) , whereas glibenclamide (10-5 M) reversed only lemakalim-induced inhibition (Figs 3B and 4) . Reversal by 6 K+ CHANNELS AND CHOLINERGIC AIR WAY RESPONSES glibenclamide for the inhibitory modulation by NPY, clonidine, DAMGO and lemakalim were 9-5 + 5 5, 1P2 + 1P2, 0, 74-3 + 5-6 %, respectively (n = 5).
RESULTS
Reversal
Effect of charybdotoxin on cholinergic response
ChTX itself significantly potentiated cholinergic contractile responses (24 6 + 9-4 %; n = 5, P < 0 05), compared with changes in time-matched control tissues (Fig. 5 ). Conversely, ChTX (10'8 M) had no effect on exogenously applied ACh (10--10-3 M) dose-response studies (Fig. 6 ). The concentrations of ACh required to cause 50 % of the maximal response (EC50), were (2-1+ 0 6) x 10-6 M with and (3 4 + 0 9) x 10-6 M without ChTX, respectively (n = 6, P > 0 05).
Effect of charybdotoxin pretreatment on the prejunctional inhibition of cholinergic nerves ChTX (10'8 M) pretreatment reduced NPY-. clonidineand DAMGO-induced prejunctional inhibition, but not lemakalim-induced inhibition (Fig. 7) ; NPY-, clonidine-, DAMGOand lemakalim-induced inhibition of cholinergic responses in these tissues were 31-4+±77 with and 53-9+9-8% without ChTX (n = 5, P < 0-05), 33-3 + 5-4 with and 54-8 + 2-3 % without ChTX (n = 5, P < 0 05), 18-6 + 5-4 with and 44-4+7-2% without ChTX (n = 5, P < 0-05) and 59-7+775 with and 61-3+8 1 % without ChTX (n = 5, P > 0-05), respectively (Fig. 8) . to a 136±+8 5 % inhibition in the presence of ChTX (n = 5, P < 0-05, Fig. 9 ). ChTX (10-M) alone did not have any significant effect on cholinergic responses in human tissues (n = 3).
DISCUSSION
The present study has demonstrated that ChTX reverses and reduces the prejunctional modulation of cholinergic responses by NPY, an x2-agonist and a Itopioid in guinea-pig airways, and that ChTX also attenuates a /t-opioid-induced 8 K+ CHANNELS AND CHOLINERGIC AIR WtA Y RESPONSES inhibitory modulation of cholinergic responses in human airways. Since ChTX does not block any other ion channels than K+ channels (Gimenez-Gallego, Navia, Reuben, Katz, Kaczorowski & Garcia, 1988) , these results may support a hypothesis that ChTX-sensitive K+ channels. presumably large conductance K'a, are involved in the prejunetional inhibition of airway cholinergic neurotransmission by agonists acting on presynaptic receptors in guinea-pig and human airways. In the guinea-pig studies, ChTX (10-M) significantly reversed NPY-, clonidine-, DAMIGOand lemakalim-induced prejunctional inhibition of cholinergic responses.
Since ChTX at this concentration had no effects on baseline tone and contractile responses induced by exogenously applied ACh, these reversal effects are likely to be prejunetional. ChTX (10m) itself also significantly potentiated EFS-induced cholinergic contractile responses, suggesting that ChTX may facilitate neurotransmission from cholinergic nerve endings. It is therefore likely that a component of the reversal by ChTX of cholinergic neural effects could be explained by facilitation of ACh release. The mechanism of cholinergic facilitation by ChTX is not certain. This mav~be explained by the blockade of ("a"-activated K' conductance by which Ca 2+ may terminate its own influx. Alternatively, the inhibition of modulatory effects of an endogenously released neuromodulator such as vasoactive intestinal polypeptide (Ellis & Farmer. 1989) or ACh itself (Fryer & Maclagan, 1984; Minette & Barnes, 1988) by ChTX may explain this facilitation. Indeed, M2autore ceptors on neurons are known to activate with K+ channels (North et al. 1987 ).
Reversal of NPY-. clonidine-and DAMGO induced inhibition byv ChTX was significantly greater than that of lemakalim-induced inhibition, although the degree of inhibition was not different among agonists (Fig. 2) . In ChTX pretreatment studies where the facilitating activities of ChTX itself were excluded from the evaluation. ChTX still significantly, reduced the inhibitory effects of NPY, clonidine 9 and DAMGO but not of lemakalim (Fig. 8) . These results suggest that the effect of ChTX on the neuromodulation by NPY, clonidine and DAMGO includes other mechanisms than the facilitation of neurotransmitter release by ChTX itself which may entirely explain the effect of ChTX on lemakalim-induced modulation. the possible explanations of the results is that the agonists directly activate ChTXsensitive K+ channels to cause the depression of the neurotransmitter release from airway cholinergic nerves. The activation of presynaptic K+ channels appears to have a tendency to stabilize membrane potential, since the reversal potential for K+ lies near the resting potential under normal conditions (Miller, 1990) . In the CNS, several receptor agonists including /a-opioids and oc2-agonists have been shown to increase K+ conductance and inhibit neurotransmitter release in neurons (North et to K+ CHfA.NVELS AND CHOLINERGIC AIRWAY RESPONSES al. 1987 ). It has also been reported that the activation of presynaptic K+ channels could produce presynaptic inhibition by shortening the action potential and consequently reducing Ca2" influx (Belardetti & Siegelbaum, 1988) . These reports may support the speculation that the direct activation of ChTX-sensitive K+ channels by the presynaptic agonists is involved in the depression of neurotransmission in airway cholinergic nerves. We have previously demonstrated that prejunctional inhibition of airway sensory nerves by ,u-opioid, ac2-agonist and NPY is achieved through the activation of ChTX-sensitive, presumably large conductance K+a (Stretton et al. 1992) . A similar mechanism may be operative in the inhibitory modulation by NPY, a2-agonist and /a-opioid of cholinergic nerves in airways. There is also another possible explanation of the present results. Ca2+-activated K+ channels, which could be activated by an increase in intracellular Ca2+ concentration, may counteract Ca2+ influx induced by action potential through changing membrane potential. In this case, the depression of presynaptic inhibition by ChTX could be explained by the reinforcement of Ca2+ influx inhibited by the presynaptic agonists. However, this may be unlikely because ChTX was specifically effective on neuromodulation induced by the agonists acting on presynaptic receptors in the present study and not lemakalim. As shown in Fig. 8 , pretreatment with ChTX (10-8 M) did not completely prevent NPY-, clonidineand DAMGO-induced modulation. Although we have not been able to examine higher concentrations of ChTX in the present study because of expense and availability of this toxin, it is possible that higher doses might give more complete inhibition. Alternatively, Ca2+ channels may also be involved. Neurotransmitter release is thought to be triggered by Ca2+ influx into the nerve terminal, which is achieved through the activation of voltage-dependent Ca2+ 2M. MIUVIRA AND OTHERS channels (Miller, 1990) . Thus, DAMGO, clonidine and NPY may directly affect the presynaptic Ca21 channels as well as K+ channels. NPY has been reported to inhibit ACh release in nodose neurons by reducing Ca21 currents directly (Wiley, Gross, Lu & MacDonald, 1990) , and ac-adrenergic inhibition of sympathetic neurotransmitter release has been demonstrated to be mediated by N-type Ca21 channel modulation (Lipscombe. Kongsamut & Tsien. 1989) . Recently, a 1a-opioid has also been reported to inhibit Ca21 currents in neurons (Schroeder, Fischbach, Zheng & MeCleskey, 1991) . Furthermore, the simultaneous stimulation of Ca2" and K+ channels by a single neuromodulator through a common pertussis toxin-sensitive G protein has been suggested (Miller, 1990) . This may be the case in airway cholinergic nerves. Kt+ (UH.ANNVXELS AN)D CHOLINERGIC AIR W1A 4 RESPOXSES In the present study, neither apamin nor glibenclamide had any effect on NPY-, clonidineand DAMGO-induced prejunctional modulation. suggesting that neither small conductance Kca nor KATP are involved in this inhibitory modulation. The activation of KA has been reported to block neurosecretion in CNS (Schmid-Antomarchi et al. 1990 ). This also seems to be the case in cholinergic neurotransmission in airways, as demonstrated functionally in the present study in vitro by the inhibitory effect of lemakalim and reversal by glibenclamide and as previously demonstrated in guinea-p)ig airways in vivo . However, the activation of K± did not occur in the receptor-operated presynaptic modulation in airway eholinergic nerves, since an K'TP blocker glibenclamide did not influence the modulatory effect ofNPY. an a2-agonist and a Iu-opioid. ChTX-sensitive K+ channels only appear to be involved in the prejunctional modulation of NPY, a2-agonists and ,u-opioids. ChTX. which was originally described as a specific blocker of large conductance Ktla (Miller et al. 1985; Gimenez-Gallego et al. 1988) , has been implicated in blockade of other tVpes of K+ channel such as intermediate conductance K+C (Reinhart et al. 1989 ) and K' (Schweitz. Bidard, Maes & Lazdunski, 1989; Vazquez, Feigenbaum. King, Kaczorowski & Garcia. 1990 ). However, the sensitivities of these K+ channels to ChTX are known to differ markedly from that of large conductance Kta (Castle. Haylett & Jenkinson, 1989) . Thus. 3 nM-ChTX is needed to cause 50% block of large conductance Kta, while more than 10-fold is required to produce a similar inhibition of Kv and intermediate conductance KCa, Since the concentration of ChTX used in the present study was 10 nm, a large conductance KCa is the most likely to be responsible for the present responses.
The present study using human tissues also showed that the addition of ChTX (10'8 m) significantly attenuated DAMGO-induced cholinergic modulation. Previous reports have shown that EFS to human airway smooth muscle causes frequencydependent biphasic responses, consisting of an initial atropine-sensitive cholinergic contraction followed by a non-adrenergic, non-cholinergic (i-NANC) relaxation (Richardson & Beland, 1976; Davis, Kannan, Jones & Daniel, 1982; Palmer, Cuss & Barnes, 1986) . Davis et al. (1982) also showed that a non-specific K+ channel blocker, tetraethylammonium (TEA), potentiated both excitatory cholinergic and i-NANC neural responses at frequencies of less than 10 Hz, suggesting that TEA potentiates neurotransmitter release from these two nerves in human airways. However, neither cholinergic contractile responses nor i-NANC responses were enhanced by ChTX (10'8 m) in the present study. It is therefore unlikely that the inhibition of DAMGOinduced prejunctional inhibition by ChTX is explained, even in part, by the facilitation of neurotransmitter release from nerve endings in human airways. This suggests that prejunctional inhibition of cholinergic bronchoconstriction may involve the activation of ChTX-sensitive K+ channels in human airways.
